Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa. Shao L, Zhong DQ, Liu YM, Wang JQ, et al. Int J Dermatol 2023;62:e542-e545.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shao L, Zhong DQ, Liu YM, Wang JQ, et al. Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa. Int J Dermatol 2023;62:e542-e545.
PMID: 37326291